P06730 (IF4E_HUMAN) Homo sapiens (Human)
Eukaryotic translation initiation factor 4E UniProtKBInterProSTRINGInteractive Modelling
217 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3);
10 identical sequences: Pongo abelii: A0A2J8TQQ5; Pan troglodytes: G2HH86, A0A6D2XVG9; Macaca nemestrina: A0A2K6AUV9; Macaca mulatta: H9ENS9; Macaca fascicularis: I7GAS4; Rhinopithecus roxellana: A0A2K6PUJ2; Rhinopithecus bieti: A0A2K6M3I5; Chlorocebus sabaeus: A0A0D9QVU1; Colobus angolensis palliatus: A0A2K5JHE0
It is possible new templates exist for this target since these models were created.
Available Structures
38 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Co-crystal structure of eIF4E with nucleotide mimetic inhibitor. |
Heteromer Q04637; | 1×5O8; 1×SO4; | ||||
| Assess | ||||||
| Crystal structure of the ternary complex of eIF4E-m7GpppA-4EBP1 peptide |
Heteromer Q13541; | 1×GTA; | ||||
| Assess | ||||||
| Improved eIF4E binding peptides by phage display guided design. |
Heteromer Q04637; | 1×MGO; | ||||
| Assess | ||||||
| Crystal structure of the ternary complex of eIF4E-M7GTP-4EBP2 peptide |
Heteromer Q13542; | 1×MGP; | ||||
| Assess | ||||||
| Co-crystal structure of eIF4E with nucleotide mimetic inhibitor. |
Heteromer Q04637; | 1×5NX; | ||||
| Assess | ||||||
| Co-crystal structure of eIF4E with nucleotide mimetic inhibitor. |
Heteromer Q04637; | 1×5O8; 1×SO4; | ||||
| Assess | ||||||
| Autonomous VH domain that interacts with eIF4E at the Capped mRNA Binding site. |
Heteromer | |||||
| Assess | ||||||
| Crystal Structure of eIF4E Bound to Glycerol and eIF4G1 peptide |
Heteromer Q04637; | 1×MGO; 1×PGE; 4×SO4; 2×GOL; | ||||
| Assess | ||||||
| Crystal structure of the human eIF4E-4EBP1 peptide complex without cap |
Heteromer Q13541; | 1×SO4; 9×UNX; | ||||
| Assess | ||||||
| Stapled-peptides tailored against initiation of translation |
Heteromer Q04637; | 1×MGT; | ||||
| Assess | ||||||
| Co-crystal structure of eIF4E with nucleotide mimetic inhibitor. |
Heteromer Q13541; | 1×5PQ; | ||||
| Assess | ||||||
| eIF4E in Complex with a Disulphide-Free Autonomous VH Domain |
Heteromer | 1×MGO; 1×MES; | ||||
| Assess | ||||||
| Crystallographic and mass spectrometric characterisation of eIF4E with N7-cap derivatives |
Heteromer Q13541; | 1×MGV; | ||||
| Assess | ||||||
| Crystallographic and mass spectrometric characterisation of eIF4E with N7-cap derivatives |
Heteromer Q13541; | 1×MGO; | ||||
| Assess | ||||||
| Crystallographic and mass spectrometric characterisation of eIF4E with N7-cap derivatives |
Heteromer Q13541; | 1×MGQ; | ||||
| Assess | ||||||
| Engineering Disulphide-Free Autonomous Antibody VH Domains to modulate intracellular pathways |
Heteromer | |||||
| Assess | ||||||
| Complex of human eIF4E with the 4E binding protein 4E-BP1 |
Heteromer Q13541; | |||||
| Assess | ||||||
| Crystal structure of the human eIF4E-eIF4G complex |
Heteromer Q04637; | 1×MGP; 2×GOL; | ||||
| Assess | ||||||
| eIF4E in Complex with a Disulphide-Free Autonomous VH Domain |
Heteromer | 1×MGO; | ||||
| Assess | ||||||
| Cap-free structure of eIF4E suggests basis for its allosteric regulation | monomer | |||||
| Assess | ||||||
| Stapled-peptides tailored against initiation of translation | monomer | 1×NO3; 3×EDO; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF EUKARYOTIC INITIATION FACTOR 4E COMPLEXED WITH 7-METHYL GTP | monomer | 1×MGP; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF EUKARYOTIC INITIATION FACTOR 4E COMPLEXED WITH 7-METHYL GPPPA | monomer | 1×GTA; | ||||
| Assess | ||||||
| Co-crystal structure of eIF4E with inhibitor | monomer | 1×6LI; 1×GOL; 4×EDO; | ||||
| Assess | ||||||
| Co-crystal structure of eIF4E with inhibitor | monomer | 1×HLI; 2×EDO; | ||||
| Assess | ||||||
| Stapled-peptides tailored against initiation of translation | monomer | 1×MGT; 4×IOD; 1×GOL; 1×CL; | ||||
| Assess | ||||||
| Stapled-peptides tailored against initiation of translation | monomer | 1×MGP; 2×PEG; 1×GOL; | ||||
| Assess | ||||||
| Crystal Structure of eIF4E in Complex with a Stapled Peptide Derivative | monomer | |||||
| Assess | ||||||
| Stapled-peptides tailored against initiation of translation | monomer | 1×MGT; | ||||
| Assess | ||||||
| Water-Bridge Mediates Recognition of mRNA Cap in eIF4E | monomer | 3×GOL; | ||||
| Assess | ||||||
| The co-complex structure of the translation initiation factor eIF4E with the inhibitor 4EGI-1 revea… | monomer | 1×MGP; 1×33R; | ||||
| Assess | ||||||
| Stapled-peptides tailored against initiation of translation | monomer | 1×MGP; | ||||
| Assess | ||||||
| The co-complex structure of the translation initiation factor eIF4E with the inhibitor 4EGI-1 revea… | monomer | 1×MGT; 1×34K; 1×MES; | ||||
| Assess | ||||||
| Crystal Structure of eIF4e in complex with Compound 7n | monomer | 1×WXL; | ||||
| Assess | ||||||
| A biphenyl inhibitor of eIF4E targeting an internal binding site enables the design of cell-permeab… | monomer | 1×MGP; 1×Z5D; | ||||
| Assess | ||||||
| The co-complex structure of the translation initiation factor eIF4E with the inhibitor 4EGI-1 revea… | monomer | 1×M7G; 1×34J; | ||||
| Assess | ||||||
| Crystal structure of the cap free human translation initiation factor eIF4E | monomer | 6×UNX; | ||||
| Assess | ||||||
| Cyclic Peptide that Interacts with the eIF4E Capped-mRNA Binding Site | monomer | 1×NA; | ||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4dt6.1.A | monomer | 0.85 | 1×6LI; | 100.00 | ||
| Assess | ||||||
2 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 4dt6.1.A | monomer | 0.72 | 1×6LI; | 100.00 | |
| Assess | ||||||
| Isoform 3 | 4dt6.1.A | monomer | 0.85 | 1×6LI; | 99.06 | |
| Assess | ||||||